E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
Hōʻike huahana
ʻO L-proline tert-butyl ester, i kapa ʻia ʻo N-(pyrrolidine-2-carbonyl) -L-proline tert-butyl ester, he mea koʻikoʻi i nā ʻoihana like ʻole, me nā lāʻau lapaʻau, synthesis kemika, a me nā mea holomua.Hana ʻia.ʻO kāna versatility a me ka laulā o nā noi e lilo ia i mea waiwai nui no nā hana ʻepekema he nui.
ʻO ke kaʻina hana synthesis o ka huahana e hahai i nā kūlana kiʻekiʻe o ka ʻoihana, e hōʻoia ana i ka maikaʻi a me ka maʻemaʻe.Hoʻohui ka molecular formula C9H17NO2 i nā mea kalapona, hydrogen, nitrogen a me ka oxygen e hana i kahi hui me ke kūpaʻa kūʻokoʻa a me ka reactivity.Me ke kaumaha o ka molekala o 171.24, hiki ke maʻalahi a maʻalahi ke ana ʻia i loko o kahi kaiapuni keʻena.
ʻO kahi waiwai koʻikoʻi o L-tert-butyl proline kona hoʻohana ākea i ka ʻoihana lāʻau.Hoʻohana ka poʻe noiʻi i kēia pūhui e synthesize i nā ʻano lāʻau lapaʻau like ʻole a me nā mea lāʻau lapaʻau ikaika (API).ʻO kāna hana kūikawā a me kāna hui hana e hiki ai ke hoʻomohala i nā lāʻau lapaʻau hou e kuhikuhi ana i nā maʻi kūikawā a me nā kūlana olakino.ʻO ka maʻemaʻe a me ka pololei o kā mākou huahana e hōʻoia i nā hopena kūpono a me nā hopena hilinaʻi i ka wā o ka hoʻomohala ʻana i ka lāʻau.
![Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid a me (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8](https://cdnus.globalso.com/jdkchemicals/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
